Last update Oct. 14, 2022
Very Low Risk
It is a penicillinase-resistant penicillin that is used in a similar way to flucloxacillin in the treatment of benzylpenicillin-resistant staphylococcal infections. Intravenous or intramuscular administration.
Since the last update we have not found published data on its excretion in breastmilk.
Its high percentage of protein binding make it highly unlikely that significant quantities will pass into breast milk.
Because it lacks of oral bioavailability, seems difficult any pass to the infant’s plasma through the breast milk ingested, except on premature infants and immediate neonatal period, in which there may be an increased intestinal permeability.
Expert authors consider the use of this medication to be safe during breastfeeding. (Hale, LacMed, Briggs 2015)
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM